SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor-Naïve Patients With Myelofibrosis. (Q49993088)
Jump to navigation
Jump to search
scientific article published on 20 September 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor-Naïve Patients With Myelofibrosis. |
scientific article published on 20 September 2017 |
Statements
1 reference
SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor-Naïve Patients With Myelofibrosis. (English)
1 reference
Ruben A Mesa
1 reference
John V Catalano
1 reference
Timothy Devos
1 reference
Miklos Egyed
1 reference
Andrzei Hellmann
1 reference
Donal McLornan
1 reference
Kazuya Shimoda
1 reference
Elliott F Winton
1 reference
Wei Deng
1 reference
Ronald L Dubowy
1 reference
Julia D Maltzman
1 reference
Francisco Cervantes
1 reference
Jason Gotlib
1 reference
20 September 2017
1 reference
35
1 reference
34
1 reference
3844-3850
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference